Kura Oncology Inc buy melinda
Start price
06.06.17
/
50%
€7.44
Target price
05.07.17
€8.57
Performance (%)
15.51%
End price
05.07.17
€8.60
Summary
This prediction ended on 05.07.17 with a price of €8.60. The BUY prediction by melinda finished with a performance of 15.51%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kura Oncology Inc | -11.588% | -11.588% | -2.217% | -28.871% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by melinda for this prediction
In the thread Kura Oncology Inc diskutieren
Healthcare | Biotechnologie | USA
Anzeige der Phase 2 mit den Daten auf der Konferenz der European Hematology Association (EHA) ab Juni 22-25 2017. Das genaue Datum TBC.
Stopped prediction by melinda for Kura Oncology Inc
Kura Oncology Inc
Start price
Target price
Perf. (%)
€10.64
06.11.18
06.11.18
€14.34
10.12.18
10.12.18
16.15%
10.12.18
10.12.18
Kura Oncology Inc
Start price
Target price
Perf. (%)
€15.33
23.09.18
23.09.18
€16.51
06.11.18
06.11.18
-27.37%
06.11.18
06.11.18
Kura Oncology Inc
Start price
Target price
Perf. (%)
€8.45
10.08.17
10.08.17
€10.50
15.08.17
15.08.17
-25.44%
15.08.17
15.08.17